Kestra Medical Technologies, Ltd. (KMTS) Financial Statements
$28.76NMS: KMTSMarket Cap $1.71B
Kestra Medical Technologies, Ltd. most recently reported annual revenue of $95.0M, a net loss of $132.0M. Revenue grew at an average annual rate of 128.1% over the last 3 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Kestra Medical Technologies, Ltd.: Revenue rose from $8.0M in 2023 to $95.0M in 2026, a change of +1087.5% over 3 years; net profit was positive in 0 of 6 reported years; operating margin moved from -1054.0% to -141.6%, a shift of +912.4 percentage points; the most recent year shows a net loss of $132.0M.
Income Statement — 6 Years (USD millions)
Metric
2020
2021
2023
2024
2025
2026
Revenue
—
—
$8.0M
$28.0M
$60.0M
$95.0M
Operating Expenses
—
—
$88.0M
$113.0M
$166.0M
$230.0M
Operating Profit
—
—
$-80.0M
$-85.0M
$-106.0M
$-135.0M
Operating Margin
0.0%
0.0%
-1054.0%
-305.8%
-177.8%
-141.6%
Other Income
—
—
$-4.0M
$-9.0M
$-7.0M
$3.0M
Interest
$0
$0
$6.0M
$6.0M
$8.0M
$8.0M
Depreciation
$0
$0
$5.0M
$12.0M
$8.0M
$-4.0M
Profit Before Tax
—
—
$-84.0M
$-94.0M
$-114.0M
$-131.0M
Tax
—
—
$-20,000
$-30,000
$-120,000
$-220,000
Net Profit
—
—
$-84.0M
$-94.0M
$-114.0M
$-132.0M
EPS
$0.00
$0.00
$-1.75
$-2.04
$-5.13
$-2.43
Dividend Payout
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Results — Last 11 Quarters (USD millions)
Metric
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue
$8.0M
$10.0M
$13.0M
$15.0M
$15.0M
$17.0M
$19.0M
$23.0M
$25.0M
$29.0M
$31.0M
Operating Expenses
$28.0M
$30.0M
$31.0M
$34.0M
$36.0M
$65.0M
$48.0M
$54.0M
$59.0M
$68.0M
$69.0M
Operating Profit
$-20.0M
$-20.0M
$-18.0M
$-19.0M
$-21.0M
$-48.0M
$-29.0M
$-32.0M
$-35.0M
$-39.0M
$-38.0M
Operating Margin
-241.0%
-202.4%
-144.2%
-130.1%
-136.5%
-279.8%
-149.1%
-140.7%
-141.6%
-137.4%
-121.6%
Interest
$2.0M
$2.0M
$2.0M
$1.0M
$2.0M
$2.0M
$2.0M
$2.0M
$2.0M
$2.0M
$2.0M
Profit Before Tax
$-22.0M
$-22.0M
$-20.0M
$-21.0M
$-22.0M
$-51.0M
$-26.0M
$-33.0M
$-34.0M
$-39.0M
$-44.0M
Tax
$-60,000
$120,000
$-30,000
$-40,000
$-80,000
$-200,000
$-130,000
$-100,000
$-100,000
$-500,000
$-110,000
Net Profit
$-22.0M
$-22.0M
$-20.0M
$-20.0M
$-22.0M
$-52.0M
$-26.0M
$-33.0M
$-34.0M
$-39.0M
$-44.0M
EPS
$-0.47
$-0.45
$-0.45
$-0.48
$-0.50
$-2.21
$-0.50
$-0.64
$-0.61
$-0.67
$-0.75
Over the 6 years reported for Kestra Medical Technologies, Ltd., cash stood at $100.0M in the latest year, shareholders' equity was $58.0M, current assets covered current liabilities 4.44 times.
Balance Sheet — 6 Years (USD millions)
Metric
2020
2021
2023
2024
2025
2026
Total Assets
$8.0M
$31.0M
$39.0M
$46.0M
$296.0M
$358.0M
Current Assets
$6.0M
$26.0M
$18.0M
$15.0M
$255.0M
$222.0M
Cash
$6.0M
$24.0M
$15.0M
$8.0M
$238.0M
$100.0M
Inventory
$0
$0
$2.0M
$3.0M
$7.0M
$7.0M
Receivables
$0
$0
$2.0M
$2.0M
$8.0M
$15.0M
Fixed Assets
$1.0M
$3.0M
$17.0M
$28.0M
$37.0M
$62.0M
Capital Work in Progress
$0
$0
$0
$0
$0
$0
Investments
$0
$0
$0
$0
$0
$162.0M
Other Assets
$0
$0
$0
$0
$0
$0
Total Liabilities
$4.0M
$29.0M
$156.0M
$255.0M
$90.0M
$99.0M
Current Liabilities
$4.0M
$7.0M
$37.0M
$33.0M
$38.0M
$50.0M
Borrowings
$0
$23.0M
$39.0M
$45.0M
$44.0M
$47.0M
Other Liabilities
$4.0M
$6.0M
$117.0M
$210.0M
$46.0M
$52.0M
Equity
$0
$0
$0
$0
$51.0M
$58.0M
Reserves
$4.0M
$2.0M
$-118.0M
$-209.0M
$205.0M
$260.0M
For Kestra Medical Technologies, Ltd., operating cash flow was positive in 0 of 6 reported years; free cash flow in the latest year was negative at $117.0M; free cash flow was positive in 0 of 6 years; financing activities used $2.0M in the latest year, which covers debt repayment, dividends and buybacks.
Cash Flow Statement — 6 Years (USD millions)
Metric
2020
2021
2023
2024
2025
2026
Operating Cash Flow
$-30.0M
$-30.0M
$-70.0M
$-72.0M
$-78.0M
$-82.0M
Investing Cash Flow
$0
$-1.0M
$-31.0M
$-25.0M
$-47.0M
$-238.0M
Financing Cash Flow
$30.0M
$29.0M
$0
$-2.0M
$13.0M
$-2.0M
Net Cash Flow
$0
$19.0M
$11.0M
$-7.0M
$229.0M
$-138.0M
Free Cash Flow
$-31.0M
$-30.0M
$-85.0M
$-85.0M
$-101.0M
$-117.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
-0.65
EV / EBITDA
-11.23
FCF Yield
-7.64%
Quick Ratio
4.69
Interest Coverage
-18.98
Return 1Y
29.01%
Return 3Y
—
Return 5Y
—
Kestra Medical Technologies, Ltd. (KMTS) financials — frequently asked questions
What is Kestra Medical Technologies, Ltd.'s annual revenue?
Kestra Medical Technologies, Ltd. (KMTS) reported annual revenue of $95.0M in its most recent fiscal year.
What is Kestra Medical Technologies, Ltd.'s net profit?
Kestra Medical Technologies, Ltd. (KMTS) reported a net loss of $132.0M in its most recent fiscal year.
What is KMTS EV/EBITDA?
Kestra Medical Technologies, Ltd.'s enterprise value to EBITDA (EV/EBITDA) ratio is -11.23. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.